pleural cancer trang 2 tải miễn phí từ TAILIEUCHUNG

"pleural cancer" trang 2 - tải miễn phí từ Tailieuchung

Study characteristics of malignant pleural effusion in the respiratory center, 103 military hospital in 5 years (2014-2019)

Study characteristics of malignant pleural effusion in the respiratory center, 103 military hospital in 5 years (2014-2019)

6 78 0

Pleural fluid osteopontin, vascular endothelial growth factor, and urokinasetype plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: A prospective cohort study

Pleural fluid osteopontin, vascular endothelial growth factor, and urokinasetype plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: A prospective cohort study

8 42 1

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity

13 27 1

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

7 41 1

Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

12 18 1

Bevacizumab-induced esophageal pleural fistula during maintenance therapy without radiation in lung cancer

Bevacizumab-induced esophageal pleural fistula during maintenance therapy without radiation in lung cancer

6 47 1

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma

24 23 1

Pleural cancer mortality in Spain: Time-trends and updating of predictions up to 2020

Pleural cancer mortality in Spain: Time-trends and updating of predictions up to 2020

8 63 1

Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples

Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples

10 80 0

Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma

Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma

12 68 0

Physician requests by patients with malignant pleural mesothelioma in Japan

Physician requests by patients with malignant pleural mesothelioma in Japan

7 78 0

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

10 52 0

Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study

Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study

7 16 1

Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion

Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion

13 28 1

Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: A comparison between cell-free DNA and extracellular vesicle-derived DNA

Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: A comparison between cell-free DNA and extracellular vesicle-derived DNA

8 35 1

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma

3 34 1

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: A systematic evaluation and meta-analysis

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: A systematic evaluation and meta-analysis

13 26 1

Management of malignant pleural mesothelioma: A French multicenter retrospective study (GFPC 0802 study)

Management of malignant pleural mesothelioma: A French multicenter retrospective study (GFPC 0802 study)

6 15 1

The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma

The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma

6 32 1

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

13 69 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.